Biomedical Regulatory Consulting (BRC) was founded in 2011 by Dr. Bill Soller to establish consulting services to the biomedical community pursuing FDA approval of applications associated with drug and device development.
BRC then further expanded to engage clients interested in building compliance to Quality System Management regulations and managing of QA programs for CRO and device companies as well as analytical research labs. BRC serves clients across the US and EU member states.
Our objective is to provide reliable, credible, cost-efficient, and time-dependable regulatory paths to market for drugs and devices.
BRC then further expanded to engage clients interested in building compliance to Quality System Management regulations and managing of QA programs for CRO and device companies as well as analytical research labs. BRC serves clients across the US and EU member states.
Our objective is to provide reliable, credible, cost-efficient, and time-dependable regulatory paths to market for drugs and devices.
Pharmaceutical
|
Medical Device Development
|
Quality Systems Management
|
|
|
|
